A Pioneer of Digital Search Dies at 95
A pioneer of digital search, Summit developed the technology at Lockheed Missiles and Space Company in the 1960s, creating one of the first online services to allow users to remotely access and search vast scientific and technical databases decades before the public internet became a staple of daily life.
Automating the Library at Lockheed
In 1966, while working for Lockheed Missiles and Space Company, Roger Summit began conceptualizing a system to automate the labor-intensive process of library research. At the time, researchers at the firm frequently noted that it was often faster to redo an experiment than to locate existing technical literature in physical card catalogs.
Summit envisioned an interactive, computer-based system that allowed a “searcher” to input queries directly to a machine. He chose the name “Dialog” to reflect this two-way communication between human and computer. By 1967, Lockheed successfully piloted the system with NASA, connecting the platform to a database of over 250,000 documents. According to documented evaluations from the time, NASA scientists reported that the system reduced search times from hours to minutes, significantly increasing productivity.
The Expansion of Commercial Access
Following the success of the NASA proof-of-concept, Lockheed expanded the platform’s utility to other government entities, including the U.S. Atomic Energy Commission and the European Space Research Organization. In 1972, the company transitioned Dialog into the commercial sector.
Dialog operated by connecting computer terminals to centralized databases via telephone lines. In 1988, Lockheed sold the Dialog service to the newspaper conglomerate Knight Ridder for $353 million. The asset has since changed ownership multiple times and is currently operated by the information-services firm Clarivate.
Foundations of the Search Era
While Dialog predated the widespread adoption of the internet and commercial search engines like Google and Yahoo, historians recognize it as a foundational influence on modern information retrieval. Marc Weber, an internet historian, has cited Summit as a key figure in the history of search, noting that Dialog was present at the inception of the field.
Summit, who held an M.B.A. from Stanford University, often compared the difficulty of finding information in the pre-digital age to searching for Ali Baba among countless oil jars. In his later years, he expressed fascination with the evolution of the technology he helped pioneer. During a 2005 presentation at Google, Summit remarked that the retrieval speeds achieved by modern search engines were “beyond my imagination.”
He is survived by his wife, Virginia Buckhorn, and their two children, Scott and Jennifer Summit.
- China Delivers Chang’e-6 Moon Samples to UN and Warns US Against Space Militarization
- China Rejects AI Slowdown Calls, Blasts US Tech Leaders’ ‘Fearmongering
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)
- Tennessee Schools Shift to Virtual Learning and Early Dismissal Due to Extreme Heat (news-usa.today)